Loading institutional data...
Loading institutional data...
Held by 516 of 5,944 reporting institutions (97th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $125.50 today, the market must believe free cash flow compounds 11.2%/yr for a decade (off $310M normalized FCF).
The market's 11.2% is more optimistic than its 9-yr track record.
2-stage DCF · 0.07B shares · net debt -$218M
mean 36.6% · volatility σ 94% · implied rate exceeded in 5/9 yrs
Central path = implied 11.2%/yr growth; shaded band = ±1σ (94%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
6/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 40% of free cash flow, leaving room to grow it and fund buybacks. Last year: $121M dividends + $365M buybacks = $486M returned on $300M FCF.
9 consecutive years of dividend increases · 5%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 14%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $402M covers the $61M due within a year 6.6× over. Scheduled principal only (excludes interest & revolver draws). As of 2018-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~28.7% on $184M of debt.
Cash of $402M fully covers short-term debt of $184M.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.78B 100.0% | $3.58B 100.0% | $3.49B 100.0% | $3.32B 100.0% | $3.23B 100.0% | $2.93B 100.0% | $2.86B 100.0% | $2.76B 100.0% | $2.47B 100.0% | $2.33B 100.0% |
| Gross Profit | — | — | — | — | — | $906.0M 30.9% | $874.4M 30.6% | $795.5M 28.8% | $723.5M 29.3% | $687.4M 29.5% |
| Research & Development | $105.1M 2.8% | $96.1M 2.7% | $92.8M 2.7% | $93.5M 2.8% | $99.8M 3.1% | $92.5M 3.2% | $82.8M 2.9% | $75.3M 2.7% | $68.2M 2.8% | $66.2M 2.8% |
| Total Operating Expenses | $3.28B 86.7% | $3.09B 86.1% | $3.08B 88.4% | $2.94B 88.6% | $2.88B 89.2% | $2.59B 88.4% | $2.49B 87.0% | $2.48B 89.6% | $2.15B 86.9% | $2.02B 86.5% |
| Operating Income | $501.0M 13.3% | $496.5M 13.9% | $404.0M 11.6% | $379.3M 11.4% | $347.3M 10.8% | $339.5M 11.6% | $371.7M 13.0% | $286.3M 10.4% | $323.5M 13.1% | $313.7M 13.5% |
| Interest Expense | $52.7M 1.4% | $43.9M 1.2% | $40.4M 1.2% | $40.8M 1.2% | $30.3M 0.9% | $33.2M 1.1% | $35.5M 1.2% | $32.6M 1.2% | $40.6M 1.6% | $35.2M 1.5% |
| Interest & Investment Income | $11.7M 0.3% | $12.1M 0.3% | $4.4M 0.1% | $2.7M 0.1% | $3.7M 0.1% | $958K 0.0% | $4.2M 0.1% | $7.1M 0.3% | $5.5M 0.2% | $2.6M 0.1% |
| Other Income (Expense), net | -$2.0M -0.1% | $3.3M 0.1% | $3.2M 0.1% | -$4.8M -0.1% | -$3.1M -0.1% | -$7.7M -0.3% | $1.6M 0.1% | $5.5M 0.2% | $6.7M 0.3% | -$407K -0.0% |
| Pretax Income | $491.4M 13.0% | $469.8M 13.1% | $374.8M 10.7% | $334.7M 10.1% | $321.7M 10.0% | $301.2M 10.3% | $342.1M 12.0% | $266.0M 9.6% | $294.8M 11.9% | $280.5M 12.0% |
| Income Tax Expense | $98.9M 2.6% | $95.6M 2.7% | $90.6M 2.6% | $95.1M 2.9% | $78.0M 2.4% | $87.1M 3.0% | $99.8M 3.5% | $71.3M 2.6% | $74.8M 3.0% | $74.9M 3.2% |
| Net Income | $392.8M 10.4% | $374.5M 10.5% | $284.5M 8.2% | $239.3M 7.2% | $244.1M 7.6% | $214.0M 7.3% | $242.2M 8.5% | $194.8M 7.0% | $220.0M 8.9% | $205.6M 8.8% |
| Per Share | ||||||||||
| EPS (Basic) | $5.97 | $5.65 | $4.34 | $3.66 | $3.72 | $3.32 | $3.81 | $3.12 | $3.52 | $3.27 |
| EPS (Diluted) | $5.89 | $5.53 | $4.25 | $3.59 | $3.61 | $3.21 | $3.66 | $3.00 | $3.41 | $3.17 |
| Weighted Avg Shares (Basic) | 65.7M | 66.3M | 65.6M | 65.4M | 65.7M | 64.4M | 63.6M | 62.4M | 62.4M | 62.8M |
| Weighted Avg Shares (Diluted) | 66.7M | 67.7M | 66.9M | 66.7M | 67.7M | 66.7M | 66.2M | 65.0M | 64.6M | 64.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 43th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Profit | 28.8 | 30.6 | 30.9 | — | — | — | — | — |
| R&D | 2.7 | 2.9 | 3.2 | 3.1 | 2.8 | 2.7 | 2.7 | 2.8 |
| Operating Income | 10.4 | 13.0 | 11.6 | 10.8 | 11.4 | 11.6 | 13.9 | 13.3 |
| Income Tax | 2.6 | 3.5 | 3.0 | 2.4 | 2.9 | 2.6 | 2.7 | 2.6 |
| Net Income | 7.0 | 8.5 | 7.3 | 7.6 | 7.2 | 8.2 | 10.5 | 10.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ATR: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| ATR | $8.3B | 21.3× | 10.2× | 2.2× | 5.4% | — | 10.4% | 14.7% | 13.8% | 0.2× | 516 |
Peers = companies sharing ATR's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.